Home › Quitting Smoking (Tobacco Use Disorder) › NCT07698470
Brain/Craving Response to Smoking Cues After Oral Nicotine Pouch Use
Cue-Exposure Response Evaluation: Brain Reactivity to ONPs
Who can join
Ages 21 to 55 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Age 21 years - 55 years * Self-reported use of cigarettes within the past 30 days * Biochemical confirmation of cigarette use: o Carbon monoxide (CO) breath sample ≥10 ppm * Fagerström Test for Nicotine Dependence (FTND) score ≥5, indicating moderate to high nicotine dependence * Fluent in English * Willing to try an oral nicotine pouch * Willing to abstain from nicotine for at least 12 hours prior to each experimental session Exclusion Criteria: * Age younger than 21 years or older than 55 years * Biochemical evidence inconsistent with recent cigarette use: o CO breath sample \<10 ppm * Expressed intent to reduce or quit nicotine use within the next 30 days * History of medical conditions contraindicated for nicotine use (e.g., uncontrolled hypertension, recent cardiac events) * Primary use of non-cigarette products (e.g., cigars, pipe tobacco, smokeless tobacco) * Prior use of oral nicotine products in their lifetime
About the study
Oral nicotine pouches (ONPs) are non-combustible nicotine products that may reduce cigarette craving and smoking cue-induced brain activity, supporting their potential as harm-reduction tools for adults who smoke cigarettes. This within-subject, repeated-measures study will evaluate the acute effects of a single 6 mg oral nicotine pouch on subjective craving and prefrontal neural responses to smoking-related cues using functional near-infrared spectroscopy (fNIRS). Participants will complete assessments before and after nicotine pouch administration following overnight nicotine abstinence to characterize changes in craving and neural cue reactivity.
What is being tested
- Oral Nicotine Pouch (other)
- Smoking Cue Reactivity Task (behavioral)
Sponsor: University of Southern California · Participants: 45 · Started: Apr 30, 2026
Contact the study team
- USC Nicotine and Tobacco Studies · Phone: 213-821-0807
Official record on ClinicalTrials.gov — NCT07698470
Locations in the U.S.
| California | University of Southern California - 3641 Watt Way (HNB B22), Los Angeles |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.